Universal Health International Group Holding Limited (2211.HK)

HKD 0.15

(-2.01%)

EBITDA Summary of Universal Health International Group Holding Limited

  • Universal Health International Group Holding Limited's latest annual EBITDA in 2023 was 12.59 Million CNY , up 115.31% from previous year.
  • Universal Health International Group Holding Limited's latest quarterly EBITDA in 2023 Q4 was 34.11 Million CNY , down 0.0% from previous quarter.
  • Universal Health International Group Holding Limited reported an annual EBITDA of -82.27 Million CNY in 2022, up 54.67% from previous year.
  • Universal Health International Group Holding Limited reported an annual EBITDA of -160.78 Million CNY in 2021, up 53.67% from previous year.
  • Universal Health International Group Holding Limited reported a quarterly EBITDA of 34.11 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • Universal Health International Group Holding Limited reported a quarterly EBITDA of -22.7 Million CNY for 2022 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Universal Health International Group Holding Limited (2023 - 2012)

Historical Annual EBITDA of Universal Health International Group Holding Limited (2023 - 2012)

Year EBITDA EBITDA Growth
2023 12.59 Million CNY 115.31%
2022 -82.27 Million CNY 54.67%
2021 -160.78 Million CNY 53.67%
2020 -560.82 Million CNY 23.25%
2019 -446.66 Million CNY -58.58%
2018 -270.12 Million CNY -25.77%
2017 -255.9 Million CNY -12644.36%
2016 -11.34 Million CNY -101.28%
2015 156.66 Million CNY -78.26%
2014 724.15 Million CNY 31.57%
2013 547.31 Million CNY 59.8%
2012 329.89 Million CNY 0.0%

Peer EBITDA Comparison of Universal Health International Group Holding Limited

Name EBITDA EBITDA Difference
China Healthwise Holdings Limited -117.45 Million HKD 110.723%
Tycoon Group Holdings Limited 147.38 Million HKD 91.455%
Beijing Tong Ren Tang Chinese Medicine Company Limited 779.54 Million HKD 98.384%